These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10368033)

  • 1. CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology.
    Noble F; Roques BP
    Prog Neurobiol; 1999 Jul; 58(4):349-79. PubMed ID: 10368033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptors.
    Noble F; Roques BP
    Neuropeptides; 2002; 36(2-3):157-70. PubMed ID: 12359506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of CCKRs and SAR studies of peptidic analog ligands.
    Noble F
    Curr Top Med Chem; 2007; 7(12):1173-9. PubMed ID: 17584139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study.
    Monstein HJ; Nylander AG; Salehi A; Chen D; Lundquist I; Håkanson R
    Scand J Gastroenterol; 1996 Apr; 31(4):383-90. PubMed ID: 8726308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin receptors.
    Wank SA
    Am J Physiol; 1995 Nov; 269(5 Pt 1):G628-46. PubMed ID: 7491953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence studies on the binding between 1-47 fragment of cholecystokinin receptor CCK(A)-R(1-47) and nonsulfated cholecystokinin octapeptide CCK8.
    Ragone R; De Luca S; Tesauro D; Pedone C; Morelli G
    Biopolymers; 2000-2001; 56(1):47-53. PubMed ID: 11582577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264.
    Durieux C; Ruiz-Gayo M; Roques BP
    Eur J Pharmacol; 1991 Dec; 209(3):185-93. PubMed ID: 1797561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin and learning and memory processes.
    Hadjiivanova C; Belcheva S; Belcheva I
    Acta Physiol Pharmacol Bulg; 2003; 27(2-3):83-8. PubMed ID: 14570153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity.
    Ren Y; Bläker M; Seshadri L; McBride EW; Beinborn M; Kopin AS
    J Mol Neurosci; 2003 Apr; 20(2):115-24. PubMed ID: 12794305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of phospholipase C by cholecystokinin receptor subtypes with different G-protein-coupling specificities in hormone-secreting pancreatic cell lines.
    Paulssen RH; Fraeyman N; Florholmen J
    Biochem Pharmacol; 2000 Sep; 60(6):865-75. PubMed ID: 10930542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholecystokinins and their receptors. Functional aspects].
    Böhme GA; Blanchard JC
    Therapie; 1992 Nov; 47(6):541-8. PubMed ID: 1301646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeling approaches for cholecystokinin B receptor imaging.
    Aloj L; Panico MR; Caracó C; Zannetti A; Del Vecchio S; Di Nuzzo C; Arra C; Morelli G; Tesauro D; De Luca S; Pedone C; Salvatore M
    Biopolymers; 2002; 66(6):370-80. PubMed ID: 12658724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors.
    Wang HL
    J Neurochem; 1997 Apr; 68(4):1728-35. PubMed ID: 9084447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
    J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
    Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
    Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-induced antinociception is not blocked by CCK-A or CCK-B receptor antagonists.
    Williams CL; Rosenfeld GC; Burks TF
    Peptides; 1997; 18(3):409-14. PubMed ID: 9145429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.